Arkolith/Insider Trading/ETON/Form 4

Opaleye Management Inc.

10% OwnerEton Pharmaceuticals, Inc. (ETON) · full profile →Form 4 · filed Jul 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.8M
Net Open-Market Flow
-$4.8M
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 7, 2026Sell(S)20K$38.37$767K2.7M
Jul 7, 2026Sell(S)7K$38.37$257K53K
Jul 6, 2026Sell(S)10K$38.00$380K2.7M
Jul 2, 2026Sell(S)65K$37.39$2.4M2.7M
Jul 2, 2026Sell(S)25K$37.39$935K60K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-032394) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML